跳至主要内容
临床试验/JPRN-UMIN000035103
JPRN-UMIN000035103已完成未知

High-density Lipoprotein Cholesterol as a Therapeutic Target for Residual Risk in Patients With Acute Coronary Syndrome - High-density Lipoprotein Cholesterol as a Therapeutic Target for Residual Risk in Patients With Acute Coronary Syndrome

Department of Cardiovascular Medicine, Wakayama Medical University0 个研究点目标入组 100 人开始时间: 2018年12月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

o differences were observed in the baseline LDL-C and HDL-C levels between the two groups. Reduction of LDL-C levels and increase of HDL-C levels were greater in the responder group. On multivariate logistic regression analysis, LDL-C levels (OR: 0.956, 95% CI: 0.921-0.993; p=0.020) and HDL-C levels (OR: 1.143; 95% CI: 1.005-1.300, p=0.041) were independent contributors for plaque stabilization.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Target PCI lesion is graft stenosis or in-stent restenosis 2) Patients who had undergone previous PCI for the lesion under evaluation. 3) Patients who have plaque in a non-culprit site on the PCI vessel that might call for PCI during the treatment period (non-culprit lesion is unrestricted) 4) Patients already receiving lipid lowering agents (HMG-CoA reductase inhibitors [statins], fibrates, probucol, nicotinic acid, anion exchange resins, or ezetimib) 5) Patients with familial hypercholesterolemia 6) Patients with cardiogenic shock 7) Patients on cyclosporine therapy 8) Patients with liver dysfunction (ALT[GPT] >= 100IU), biliary obstruction and/or defective hepatic metabolism: acute hepatitis, acute exacerbation of chronic hepatitis, liver cirrhosis, hepatic carcinoma and/or icterus 9) Pregnant and possibly pregnant women, lactating women 10) Patients with renal dysfunction (serum creatinine >=2.0 mg/dL) or on maintenance dialysis 11) Patients who are judged by the principal or other investigator to be ineligible for enrollment in the study

研究者

发起方
Department of Cardiovascular Medicine, Wakayama Medical University

相似试验